Company
Headquarters: Dongguan, China
Employees: 1,360
CN¥7.43 Billion
CNY as of Jan. 1, 2025
US$1.02 Billion
| Company | Market Cap (USD) |
|---|---|
| Abbott | $213.72 B |
| Stryker | $150.01 B |
| Boston Scientific Corporation | $149.80 B |
| Medtronic | $114.44 B |
| Shenzhen Mindray Bio-Medical Electronics Co. Ltd | $47.37 B |
| Company | Market Cap (USD) |
|---|---|
| Lilly | $689.42 B |
| Novo Nordisk | $622.07 B |
| UnitedHealth Group | $487.54 B |
| Johnson & Johnson | $353.05 B |
| AbbVie | $301.60 B |
INKON Life Technology Co., Ltd. researches, develops, produces, and sells edible mushrooms in China and internationally. The company's products include fresh brown shimeji, white shimeji, needle, and king oyster mushrooms. It also engages in the development, production, sale, and maintenance of gamma ray stereotactic radiotherapy treatment system; construction and operation of radiation oncology treatment centers; and investments business. The company was formerly known as Starmap Medicine and Technology Co., Ltd. and changed its name to INKON Life Technology Co., Ltd. in July 2019. INKON Life Technology Co., Ltd. was founded in 1998 and is headquartered in Dongguan, China.
Top 1-year algo backtest: +327.04%
$10,000 in March 2024 would now be $42,704 by following this algorithm daily at market close.
Use AI to boost your investing & swing trading, now!
Try Disfold DeepFinance FREE
INKON Life Technology Co. Ltd has the following listings and related stock indices.
Stock: SZSE: 300143 wb_incandescent